Also Moderna vaccine previously reviewed by European Medicines Agency | NOW

The Moderna vaccine, like the Pfizer vaccine, is being assessed earlier than expected by the European medicine agency EMA. The vaccine is expected to be approved or rejected on January 6, the EMA reports Thursday.

The EMA writes that the American company has already provided the latest data on Thursday. This also allows the assessment to take place earlier.

The European Union recently signed a contract with Moderna. The vaccine developer will deliver 80 million doses and the EU has the option to purchase another 80 million doses.

The Netherlands receives 3.89 percent of all vaccines. This means that the Netherlands will receive more than three million doses of the Moderna vaccine and can vaccinate about 1.6 million people. People must be given two doses to be protected.

The Moderna vaccine appears to be 94.5 percent effective. As with the Pfizer vaccine, it uses an RNA vaccine.

On Monday, the EMA will issue a ruling on the Pfizer vaccine. That too is ahead of schedule. A spokesperson for that company said on Thursday that he had a small stock available for the Netherlands before the end of the year.

On Thursday it was announced that EU countries want to start vaccination campaigns on December 27, 28 and 29. Minister Hugo de Jonge (Public Health) reported on Thursday that the Netherlands will start later and expect the first vaccinations on January 8.


Leave a Reply

Your email address will not be published. Required fields are marked *